reports
- Jonathan Moreland
TTSH TILE SHOP HOLDINGS INC.
PLUG PLUG POWER INC.
MAIN MAIN STREET CAPITAL CORPORATION
PATK PATRICK INDUSTRIES INC.
ELY CALLAWAY GOLF COMPANY
UEIC UNIVERSAL ELECTRONICS INC.
UIHC UNITED INSURANCE HOLDINGS CORP.
FLWS 1-800-FLOWERS.COM CL A
SNDX SYNDAX PHARMACEUTICALS
NNBR NN
OCSL INC.
MPB OAKTREE SPECIALTY LENDING CORPORATION
ENR MID PENN BANCORP INC.
ZYME EDGEWELL PERSONAL CARE COMPANY
ARQT ZYMEWORKS INC.
HQL ARCUTIS BIOTHERAPEUTICS
ADV INC.
CVRX TEKLA LIFE SCIENCES INVESTORS
SRPT ADVANTAGE SOLUTIONS INC (A)
DMA CVRX
SUNS INC.
EVM SAREPTA THERAPEUTICS
TXO INC.
GF DESTRA MULTI ALTERNATIVE FUND
FG SUNRISE REALTY TRUST
IAE EATON VANCE INSD CALIF MUN BD FD
MORNINGSTAR PARTNERS
L.P.
THE NEW GERMANY FUND
INC.
F AND G ANNUITIES AND LIFE
INC.
ING ASIA PACIFIC HIGH DIVIDEND EQUITY INCOME FUND
- Jonathan Moreland
CMI CUMMINS INC.
NCR NCR CORPORATION
UNH UNITEDHEALTH GROUP INCORPORATED
OEC ORION ENGINEERED CARBONS SA
LGND LIGAND PHARMACEUTICALS INCORPORATED
JRVR JAMES RIVER GROUP HOLDINGS LTD
IFF INTERNATIONAL FLAVORS & FRAGRANCES INC.
HUM HUMANA INC.
GLP GLOBAL PARTNERS LP
BRKR BRUKER CORPORATION
ASYS AMTECH SYSTEMS INC.
ERII ENERGY RECOVERY INC.
ELY CALLAWAY GOLF COMPANY
HTLD HEARTLAND EXPRESS INC.
VSH VISHAY INTERTECHNOLOGY INC.
GCBC GREENE COUNTY BANCORP INC.
WINA WINMARK CORP.
GBLI GLOBAL INDEMNITY PLC
AMBC AMBAC FINANCIAL GROUP INC.
NNBR NN
LILA INC.
COLD LIBERTY LATIN AMERICA A
EAF AMERICOLD REALTY TRUST
ULBI GRAFTECH INTERNATIONAL
MIDD ULTRALIFE
ENR THE MIDDLEBY CORPORATION
RPAY EDGEWELL PERSONAL CARE COMPANY
PRG REPAY HOLDINGS (A)
LESL PROG HOLDINGS
GRNT INC.
ALKT LESLIES
CVRX GRANIT SKOPKE
MINM ALKAMI TECHNOLOGY
MYO INC.
FLNC CVRX
DCGO INC.
STGW MINIM
OGN INC.
PFHC MYOMO
RXO_w FLUENCE ENERGY INC
OABI DOCGO INC
WEST STAGWELL INC
SRPT ORGANON & CO
FTK PROFRAC HLDG CORP
TXO RXO INC
AESI OMNIAB INC
FINS WESTROCK COFFEE COMPANY LLC
SAREPTA THERAPEUTICS
INC.
FLOTEK INDUSTRIES INC.
MORNINGSTAR PARTNERS
L.P.
ATLAS ENERGY SOLUTIONS INC.
ANGEL OAK FINANCIAL STRATEGIES INCOME TERM TRUST
- Jonathan Moreland
UNH UNITEDHEALTH GROUP INCORPORATED
PEB PEBBLEBROOK HOTEL TRUST
JRVR JAMES RIVER GROUP HOLDINGS LTD
HUM HUMANA INC.
GLP GLOBAL PARTNERS LP
FISV FISERV INC.
ASYS AMTECH SYSTEMS INC.
HTLD HEARTLAND EXPRESS INC.
EB EVENTBRITE
MIDD THE MIDDLEBY CORPORATION
RPAY REPAY HOLDINGS (A)
DLHC DALEIGH HOLDINGS CORP
GRNT GRANIT SKOPKE
ALKT ALKAMI TECHNOLOGY
PFHC INC.
RXO_w PROFRAC HLDG CORP
WEST RXO INC
FTK WESTROCK COFFEE COMPANY LLC
FG FLOTEK INDUSTRIES INC.
AESI F AND G ANNUITIES AND LIFE
FINS INC.
LBTYK ATLAS ENERGY SOLUTIONS INC.
ANGEL OAK FINANCIAL STRATEGIES INCOME TERM TRUST
LIBERTY GLOBAL LTD.
- Jonathan Moreland
OEC ORION ENGINEERED CARBONS SA
LTRX LANTRONIX INC.
LGND LIGAND PHARMACEUTICALS INCORPORATED
NEWT NEWTEK BUSINESS SERVICES INC.
HTLD HEARTLAND EXPRESS INC.
UEIC UNIVERSAL ELECTRONICS INC.
VSH VISHAY INTERTECHNOLOGY INC.
FLL FULL HOUSE RESORTS INC.
FLWS
NINE 1-800-FLOWERS.COM CL A
CNX NINE ENERGY SERVICE INC
A2H9KJ CONSOL ENERGY INC.
TCPC NEO PERFORMANCE MATERIAL
MIDD BLACKROCK TCP CAPITAL CORP.
ENR THE MIDDLEBY CORPORATION
PHAT EDGEWELL PERSONAL CARE COMPANY
DLHC PHATHOM PHARMACEUTICALS
MINM DALEIGH HOLDINGS CORP
STGW MINIM
NVCT INC.
PFHC STAGWELL INC
RXO_w NUVECTIS PHARMA INC
FTK PROFRAC HLDG CORP
NCDL RXO INC
DMA FLOTEK INDUSTRIES INC.
GF NUVEEN CHURCHILL DIRECT LENDING CORP
IAE DESTRA MULTI ALTERNATIVE FUND
THRM THE NEW GERMANY FUND
AESI INC.
ING ASIA PACIFIC HIGH DIVIDEND EQUITY INCOME FUND
SOLTA MEDICAL, INC
ATLAS ENERGY SOLUTIONS INC.
BioAtla Reports First Quarter 2025 Financial Results and Highlights Re...
BioAtla Reports First Quarter 2025 Financial Results and Highlights Recent Progress CAB-EpCAM x CAB-CD3 (BA3182) Phase 1 dose-escalation study ongoing, dosed first three patients at 300 micrograms; data readout expected mid-2025 with dose expansion data readout anticipated 1H 2026Mecbotamab vedotin (Mec-V; CAB-AXL-ADC) continues to demonstrate exceptional overall survival (OS) with a 2-year landmark survival of 59% in mKRAS non-small cell lung cancer (NSCLC); Previous studies have reported 2-year landmark survival less than 20% among patients treated with standard of care agentsOzuriftamab ...
BioAtla to Participate in the Citizens Life Sciences Conference
BioAtla to Participate in the Citizens Life Sciences Conference SAN DIEGO, April 30, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today announced that the Company’s management will provide a corporate update and participate in one-on-one investor meetings at the Citizens Life Sciences Conference, to be held in New York, NY May 7-8, 2025. Format: Corporate update and one-on-one investor meetingsDate: Wednesday, M...
BioAtla to Announce First Quarter 2025 Financial Results and Provide B...
BioAtla to Announce First Quarter 2025 Financial Results and Provide Business Highlights on May 6, 2025 SAN DIEGO, April 29, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today announced that it plans to host a conference call and webcast on Tuesday, May 6, 2025 at 4:30 p.m. ET to discuss its financial results for the first quarter ended March 31, 2025 and provide business highlights. Conference Call and Webcas...
BioAtla Announces Poster Presentations at the 2025 American Associatio...
BioAtla Announces Poster Presentations at the 2025 American Association for Cancer Research (AACR) Annual Meeting SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today announced preclinical poster presentations at the upcoming 2025 American Association for Cancer Research (AACR) to be held at the McCormick Place Convention Center in Chicago, IL from April 25–30, 2025. Two abstracts accepted fo...
BioAtla Announces Upcoming Poster Presentation at the 2025 American So...
BioAtla Announces Upcoming Poster Presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today announced a poster presentation at the upcoming 2025 American Society of Clinical Oncology (ASCO) Annual Meeting to be held online and at the McCormick Place Convention Center in Chicago, Illinois from May 30–June 3, 2025. ...
BioAtla Reports Fourth Quarter and Full Year 2024 Financial Results an...
BioAtla Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Progress CAB-EpCAM x CAB-CD3 (BA3182) Phase 1 dose-escalation study continues with data readout expected mid-2025; Dose expansion data readout anticipated 1H 2026 Mecbotamab vedotin (CAB-AXL-ADC) Q2W dosing regimen associated with exceptional overall survival (OS) with 66% and 58% of patients with mKRAS NSCLC alive at a landmark one-year and two-years, respectively, which exceeds the reported standard of care Ozuriftamab vedotin (CAB-ROR2-ADC) demonstrated compelling anti-tumor activity in treatment-r...
- Jonathan Moreland
BioAtla Announces Two Poster Presentations at Upcoming Medical Meeting...
BioAtla Announces Two Poster Presentations at Upcoming Medical Meetings SAN DIEGO, March 20, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today announced two abstracts accepted for poster presentations at the upcoming European Lung Cancer Congress (ELCC) 2025 Scientific Committee and Mayo Clinic Multidisciplinary Head and Neck Cancer Symposium 2025, to be held in Paris, France from March 26–29, 2025 and in Scotts...
BioAtla to Announce Fourth Quarter and Full-Year 2024 Financial Result...
BioAtla to Announce Fourth Quarter and Full-Year 2024 Financial Results and Provide Business Highlights on March 27, 2025 SAN DIEGO, March 19, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today announced that it plans to host a conference call and webcast on Thursday, March 27, 2025 at 4:30 p.m. ET to discuss its financial results for the fourth quarter and full-year ended December 31, 2024 and provide business h...
- Jonathan Moreland
PSEC PROSPECT CAPITAL CORPORATION
OPK OPKO HEALTH INC.
FRPT FRESHPET INC
HRTG HERITAGE INSURANCE HOLDINGS INC.
CULP CULP INC.
MAC MACERICH COMPANY
ORN ORION GROUP HOLDINGS
TREE LENDINGTREE INC.
NKSH NATIONAL BANKSHARES INC.
FLWS 1-800-FLOWERS.COM CL A
MX MAGNACHIP SEMICONDUCTOR CORP.
TCPC BLACKROCK TCP CAPITAL CORP.
XAIR BEYOND AIR
CMPR CIMPRESS PLC
ENX EATON VANCE NEW YORK MUNICIPAL BOND FUND
PRDO PERDOCEO EDUCATION CORP
FET FORUM ENERGY TECHNOLOGIES
SEAT VIVID SEATS INC.
FLNC FLUENCE ENERGY INC
BTMD HAYMAKER ACQUISITION CORP III
ECAT BLACKROCK ESG CAP ALLOCATION TR
ONL ORION OFFICE REIT INC
MLYS MINERALYS THERAPEUTICS INC
DK DELEK US HOLDINGS
CVI INC.
CUBA CVR ENERGY
SUNS INC.
AFCG THE HERZFELD CARIBBEAN BASIN FUND
INC.
SUNRISE REALTY TRUST
AFC GAMMA
INC.
- Nicholas Cortellucci
- CFA
MS Microcaps Conference: Company Spotlights & Key Takeaways
We recently teamed up with MS Microcaps to publish Company Spotlight reports on the companies presenting at its conference earlier this month. The reports aim to serve as an introduction to each company and provide a basic investment thesis. For access to full versions of all interviews please visit either mscliffnotes.substack.com or geoinvesting.com/free-trial/. Companies Mentioned: Marpai Inc. (MRAI:OTC) HireQuest Inc. (HQI:NASDAQ) QHSLab Inc. (USAQ:OTC) ACCESS Newswire Inc. (ACCS:NYSE) B...
BRM. BIOREM INC.
FTG FIRAN TECHNOLOGY GROUP CORP.
INX INTOUCH INSIGHT LTD
BLM BLUEMETRIC ENVIRONMENTAL INC
DAIO DATA I/O CORP.
IEHC IEH CORP.
CCEL CRYO-CELL INTERNATIONAL
ISDR ISSUER DIRECT CORP.
TSSI TSS INC
FPAY FLEXSHOPPER
DPDW DEEP DOWN
HQI HIREQUEST INC.
FSI FLEXIBLE SOLUTIONS INTL INC
MRAI MARPAI INC
MIND MIND GYM LIMITED
BOF BRANCHOUT FOOD INC.
USAQ QHSLAB
QUIK INC.
QUICKLOGIC CORP
- Jonathan Moreland
AAON AAON INC.
TTSH TILE SHOP HOLDINGS INC.
TCBI TEXAS CAPITAL BANCSHARES INC.
I3N CHART INDUSTRIES INC.
CDXS CODEXIS
APLE APPLE HOSPITALITY REIT INC
TDW TIDEWATER INC
RC GRUPO RADIO CENTRO S.A.B. DE C.V.
ONEW ONEWATER MARINE
CMTG CLAROS MORTGAGE TRUST
CLVT INC.
VSCO CLARIVATE PLC
MCVT VICTORIA'S SECRET & CO
ECAT MILL CITY VENTURES III LTD
SBGI BLACKROCK ESG CAP ALLOCATION TR
DK SINCLAIR INC
CUBA DELEK US HOLDINGS
VG INC.
FDBC THE HERZFELD CARIBBEAN BASIN FUND
INC.
VENTURE GLOBAL INC.
FIDELITY D & D BANCORP INC
- Jonathan Moreland
GPN GLOBAL PAYMENTS INC.
MGPI MGP INGREDIENTS INC.
KRO KRONOS WORLDWIDE INC.
I3N CHART INDUSTRIES INC.
FRPT FRESHPET INC
CRMT AMERICA'S CAR-MART INC.
BUSE FIRST BUSEY CORPORATION
ASYS AMTECH SYSTEMS INC.
AAP ADVANCE AUTO PARTS INC.
CULP CULP INC.
KYN KAYNE ANDERSON MLP INVESTMENT CO.
FLWS 1-800-FLOWERS.COM CL A
FCNCA FIRST CITIZENS BANCSHARES INC. CLASS A
NFE NEW FORTRESS ENERGY
AMPY AMPLIFY ENERGY
RC GRUPO RADIO CENTRO S.A.B. DE C.V.
AWRE AWARE INC.
PFBX PEOPLES FINANCIAL CORP. (MISSISSIPPI)
VSCO VICTORIA'S SECRET & CO
ECAT BLACKROCK ESG CAP ALLOCATION TR
SBGI SINCLAIR INC
CVI CVR ENERGY
SRBK INC.
CUBA SR BANCORP INC
BHRB THE HERZFELD CARIBBEAN BASIN FUND
SUNS INC.
VG BURKE HERBERT FINANCIAL SERVICES CORP
SUNRISE REALTY TRUST
VENTURE GLOBAL INC.
- Jonathan Moreland
UCTT ULTRA CLEAN HOLDINGS INC.
TTSH TILE SHOP HOLDINGS INC.
TRS TRIMAS CORPORATION
SRE SEMPRA ENERGY
SHEN SHENANDOAH TELECOMMUNICATIONS COMPANY
MGPI MGP INGREDIENTS INC.
MPLX MPLX LP
PETS PETMED EXPRESS INC.
TREE LENDINGTREE INC.
STXS STEREOTAXIS
ELAN ELANCO ANIMAL HEALTH INC.
NFE NEW FORTRESS ENERGY
GRX THE GABELLI HEALTHCARE & WELLNESSRX TRUST
RC GRUPO RADIO CENTRO S.A.B. DE C.V.
ABCL ABCELLERA BIOLOGICS
ALIT ALIGHT
IE INC. / DELAWARE
ECAT IVANHOE ELECTRIC INC
MEGI BLACKROCK ESG CAP ALLOCATION TR
SMRT MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
CUBA SMARTRENT INC
PSBD THE HERZFELD CARIBBEAN BASIN FUND
BHRB INC.
VG PALMER SQUARE CAPITAL BDC INC
BURKE HERBERT FINANCIAL SERVICES CORP
VENTURE GLOBAL INC.
- Jonathan Moreland
HSII HEIDRICK & STRUGGLES INTERNATIONAL INC.
EVH
CE EVOLENT HEALTH INC CLASS A
CDXS CELANESE CORPORATION
APPS CODEXIS
AAP DIGITAL TURBINE
MEDP ADVANCE AUTO PARTS INC.
FSLR MEDPACE HOLDINGS INC.
NSA FIRST SOLAR INC.
CLF NATIONAL STORAGE AFFILIATES TRUST
RCII CLIFFS NATURAL RESOURCES INC.
STXS RENT-A-CENTER INC
GRX STEREOTAXIS
AMPY THE GABELLI HEALTHCARE & WELLNESSRX TRUST
RC AMPLIFY ENERGY
ACA GRUPO RADIO CENTRO S.A.B. DE C.V.
ENX ARCOSA
BIGC EATON VANCE NEW YORK MUNICIPAL BOND FUND
CZR BIGCOMMERCE HOLDINGS
NOG INC.
PRDO CAESARS ENTERTAINMENT INC
ABCL NORTHERN OIL AND GAS
UAN PERDOCEO EDUCATION CORP
INDI ABCELLERA BIOLOGICS
IE CVR PARTNERS LP
ECAT INDIE SEMICONDUCTOR INC
MEGI IVANHOE ELECTRIC INC
RCEL BLACKROCK ESG CAP ALLOCATION TR
SBGI MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
TKO AVITA MEDICAL INC
CUBA SINCLAIR INC
BHRB TKO GROUP HOLDINGS
GAM INC.
SUNS THE HERZFELD CARIBBEAN BASIN FUND
GF INC.
BURKE HERBERT FINANCIAL SERVICES CORP
GENERAL DE ALQUILER DE MAQUINARIA
SUNRISE REALTY TRUST
THE NEW GERMANY FUND
INC.
AMREP Reports Third Quarter Fiscal 2025 Results
AMREP Reports Third Quarter Fiscal 2025 Results HAVERTOWN, Pa., March 07, 2025 (GLOBE NEWSWIRE) -- AMREP Corporation (NYSE:AXR) today reported net income of $717,000, or $0.13 per diluted share, for its 2025 fiscal third quarter ended January 31, 2025 compared to net income of $92,000, or $0.02 per diluted share, for the same period of the prior year. For the first nine months of 2025, AMREP had net income of $8,823,000, or $1.64 per diluted share, compared to net income of $2,546,000, or $0.48 per diluted share, for the same period of 2024. Revenues were $7,520,000 and $38,516,000 for th...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.